Horsetail herb API Manufacturers

compare suppliers & get competitive offers

Filters

Reset

Selected filters:

Type
Production region
Qualifications

 

 

 

To view suppliers for this material, you need to be logged in first.

 

 

 

 

 

This is because of international laws regarding narcotic materials. Furthermore, the contents of this page are only accessible if you are professionaly active in the pharmaceutical industry. In case you are, it is possible to register on our platform, and after your account is approved by our team you will be able to view suppliers and send your request.

 

 

Looking for Horsetail herb API ?

Description:
Here you will find a list of producers, manufacturers and traders of Horsetail herb. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Horsetail herb 
Synonyms:
Heermoes kruid , Prele tige , Paardestaart  
Cas Number:
 
DrugBank number:
 
Unique Ingredient Identifier:

Horsetail herb is a type of Urinary antiseptics


Urinary antiseptics are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that are specifically formulated to combat infections and promote the overall health of the urinary system. These APIs are widely used in the treatment of urinary tract infections (UTIs) caused by bacteria.

Urinary antiseptics work by exerting their antimicrobial properties within the urinary tract, preventing the growth and proliferation of bacteria. They achieve this through various mechanisms, such as interfering with bacterial cell wall synthesis, inhibiting bacterial enzymes, or disrupting essential metabolic processes.

One commonly used urinary antiseptic is Nitrofurantoin, which is effective against a broad spectrum of bacteria commonly associated with UTIs. Another notable API in this subcategory is Methenamine, which is converted to formaldehyde within the urinary tract, providing a potent bactericidal effect.

These APIs are typically formulated into oral dosage forms such as tablets or capsules, which are conveniently administered to patients. They are readily absorbed from the gastrointestinal tract and excreted via the kidneys into the urine, allowing for direct contact with the site of infection.

Urinary antiseptics are highly effective in treating UTIs, and their use has been proven to alleviate symptoms, eliminate bacteria, and prevent recurrent infections. However, like any medication, they may have potential side effects and drug interactions. Therefore, it is important for healthcare professionals to carefully assess patients' medical histories and provide appropriate guidance and monitoring during treatment.

In conclusion, urinary antiseptics are a vital subcategory of pharmaceutical APIs that play a crucial role in the treatment of urinary tract infections. Their ability to combat bacterial growth and promote urinary health makes them a valuable therapeutic option for patients suffering from UTIs.


Horsetail herb (Urinary antiseptics), classified under Anti-infective Agents


Anti-infective agents are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of various infectious diseases. These agents play a crucial role in combating bacterial, viral, fungal, and parasitic infections. The demand for effective anti-infective APIs has grown significantly due to the increasing prevalence of drug-resistant microorganisms.

Anti-infective APIs encompass a wide range of substances, including antibiotics, antivirals, antifungals, and antiparasitics. Antibiotics are particularly important in fighting bacterial infections and are further categorized into different classes based on their mode of action and target bacteria. Antivirals are designed to inhibit viral replication and are essential in the treatment of viral infections such as influenza and HIV. Antifungals combat fungal infections, while antiparasitics are used to eliminate parasites that cause diseases like malaria and helminthiasis.

The development and production of high-quality anti-infective APIs require stringent manufacturing processes and adherence to regulatory standards. Pharmaceutical companies invest heavily in research and development to discover new and more effective anti-infective agents. Additionally, ensuring the safety, efficacy, and stability of these APIs is of utmost importance.

The global market for anti-infective APIs is driven by factors such as the rising incidence of infectious diseases, the emergence of new and drug-resistant pathogens, and the growing demand for improved healthcare infrastructure. Continuous advancements in pharmaceutical technology and the development of innovative drug delivery systems further contribute to the expansion of this market.

In conclusion, anti-infective agents are a critical category of pharmaceutical APIs that play a pivotal role in treating infectious diseases. Their effectiveness in combating various types of infections makes them essential components in the arsenal of modern medicine.